5mon
Investor's Business Daily on MSNBausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?so private equity would make for a cleaner transaction," he said. Representatives of Bausch + Lomb declined to comment in an email to Investor's Business Daily. The company is worth about $13.4 ...
BLCO may be sold in 2025 to service the debt of majority shareholder BHC, and any sale will be at a premium to the current stock price. Explore more details here.
and Daily SiHy lenses and Bausch + Lomb ULTRA ® in our contact lens business. Surgical segment revenue was $231 million for the fourth quarter of 2024, as compared to $204 million for the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results